Phase 1CompletedINTERVENTIONAL
Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
ClinicalTrials.gov · NCT00873223 · Registry updated: 2017-01-26
- Condition / research focus
- Diabetes; Diabetes Mellitus, Type 2
- Sponsor
- Novo Nordisk A/S
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2009-03. Completion: 2009-09 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- liraglutide (drug)
- insulin detemir (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Novo Nordisk Investigational Site
Chula Vista, California, United States
Site recruitment: Not reported